| Dr Brent A Barber, MD | |
|
933 Red Apple Rd, Wenatchee, WA 98801-3370 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Dr Brent A Barber |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 34 Years |
| Location | 933 Red Apple Rd, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023014065 | NPI | - | NPPES |
| 315736 | Other | WA | L&I POST 7/21/13 |
| 8177149 | Medicaid | WA | |
| 258652 | Other | WA | L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00032810 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
Under the direction of Prof. Dr. Anette Ziegler, scientists of the Diabetes Research Group at Helmholtz Zentrum München and Technische Universität München investigated the formation of antibodies to a zinc transporter in children with elevated risk for type 1 diabetes. The study provided indications of an early onset of the disease when specific antibodies in the blood and specific variants of the associated zinc transporter are present in the genome.
Low doses of radiation, such as those received in the nuclear industry, are associated with a small excess risk of developing cancer, according to a study published online by the BMJ today.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
In a new survey of mental health patients in New South Wales it was found that many have struggled to gain access to a doctor. The state's Ministry of Health paid for the survey by an advocacy body, the NSW Consumer Advisory Group - Mental Health Inc. The group questioned 3,500 patients for the survey and will hand the results of the Action and Change in NSW Mental Health Services report to the State Government.
› Verified 1 days ago
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
Under the direction of Prof. Dr. Anette Ziegler, scientists of the Diabetes Research Group at Helmholtz Zentrum München and Technische Universität München investigated the formation of antibodies to a zinc transporter in children with elevated risk for type 1 diabetes. The study provided indications of an early onset of the disease when specific antibodies in the blood and specific variants of the associated zinc transporter are present in the genome.
Low doses of radiation, such as those received in the nuclear industry, are associated with a small excess risk of developing cancer, according to a study published online by the BMJ today.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
In a new survey of mental health patients in New South Wales it was found that many have struggled to gain access to a doctor. The state's Ministry of Health paid for the survey by an advocacy body, the NSW Consumer Advisory Group - Mental Health Inc. The group questioned 3,500 patients for the survey and will hand the results of the Action and Change in NSW Mental Health Services report to the State Government.
› Verified 1 days ago
| Entity Name | Wenatchee Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
Under the direction of Prof. Dr. Anette Ziegler, scientists of the Diabetes Research Group at Helmholtz Zentrum München and Technische Universität München investigated the formation of antibodies to a zinc transporter in children with elevated risk for type 1 diabetes. The study provided indications of an early onset of the disease when specific antibodies in the blood and specific variants of the associated zinc transporter are present in the genome.
Low doses of radiation, such as those received in the nuclear industry, are associated with a small excess risk of developing cancer, according to a study published online by the BMJ today.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
In a new survey of mental health patients in New South Wales it was found that many have struggled to gain access to a doctor. The state's Ministry of Health paid for the survey by an advocacy body, the NSW Consumer Advisory Group - Mental Health Inc. The group questioned 3,500 patients for the survey and will hand the results of the Action and Change in NSW Mental Health Services report to the State Government.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brent A Barber, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: () - | Dr Brent A Barber, MD 933 Red Apple Rd, Wenatchee, WA 98801-3370 Ph: (509) 663-8711 |
News Archive
Under the direction of Prof. Dr. Anette Ziegler, scientists of the Diabetes Research Group at Helmholtz Zentrum München and Technische Universität München investigated the formation of antibodies to a zinc transporter in children with elevated risk for type 1 diabetes. The study provided indications of an early onset of the disease when specific antibodies in the blood and specific variants of the associated zinc transporter are present in the genome.
Low doses of radiation, such as those received in the nuclear industry, are associated with a small excess risk of developing cancer, according to a study published online by the BMJ today.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a novel mechanism regulating the development of breast cancer bone metastases and showed that heparin-like compounds can potentially be used to inhibit breast cancer metastasis to bone.
In a new survey of mental health patients in New South Wales it was found that many have struggled to gain access to a doctor. The state's Ministry of Health paid for the survey by an advocacy body, the NSW Consumer Advisory Group - Mental Health Inc. The group questioned 3,500 patients for the survey and will hand the results of the Action and Change in NSW Mental Health Services report to the State Government.
› Verified 1 days ago
Dr. Ahmad Sabih Musmar, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 933 Red Apple Rd, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Jonathan Andrew Bolles, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St Ste A, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Brett J. Hiendlmayr, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-662-1511 | |
Kevin Joseph Struzzieri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mircea Batanoiu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 Fax: 509-665-6065 | |
Dr. Mark Douglas Johnson, M.D., MTM&H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 933 Red Apple Rd, Wenatchee, WA 98801 Phone: 509-665-6210 Fax: 509-667-3310 |